11/28/2017
https://congress.gov...
"There clearly needs to be some balance between the exclusivity and the cost savings."
"I share your concern about the seemingly ever increasing cost of drugs and its impact on both patients and on the health care system as a whole."
"I seriously question whether a lengthy exclusivity will achieve the kind of savings we all hope to see."
"And the problem I have is if we grant exclusivity, we are essentially giving the pharmaceutical free rein to charge whatever it wants during that time period."